News Headlines Article

Use of advanced prostate cancer treatments growing fast in low-risk patients, researchers say
Modern Healthcare

A growing number of men who are unlikely to benefit from advanced treatment technologies for prostate cancer are receiving expensive intensity-modulated radiotherapy and robotic prostatectomies even though they are more likely to die with—rather than from—the disease, according to a report in the Journal of the American Medical Association.

Among men with low-risk cases of the disease, use of advanced treatment technologies increased to 44% in 2009 from 32% in 2004, according to a study led by researchers from the University of Michigan at Ann Arbor.

Commands